Press Release

Bolt Biotherapeutics Prices Upsized Initial Public Offering

Press Release

Bolt Biotherapeutics Expands Board of Directors with Appointment of Kathleen LaPorte

Press Release

Bolt Biotherapeutics Presents Ongoing Clinical Trial Poster at San Antonio Breast Cancer Symposium 2020 Virtual Meeting

Press Release

Data Published in Nature Cancer Highlight Preclinical Proof of Concept of Bolt Biotherapeutics’ Boltbody™ ISAC Platform

Press Release

Bolt Biotherapeutics Presents BDC-1001 Ongoing Clinical Trial Design and Supportive Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting

Press Release

Bolt Biotherapeutics Closes $93.5 Million Series C Financing

Press Release

Bolt Biotherapeutics Announces Issuance of U.S. Patent for the Boltbody™ ISAC Technology and its Lead Development Candidate, BDC-1001

Press Release

Bolt Biotherapeutics Appoints William P. Quinn as Chief Financial Officer

Press Release

Bolt Biotherapeutics Appoints Edith Perez, M.D., as Chief Medical Officer

Press Release

Bolt Biotherapeutics Appoints Nathan Ihle, Ph.D., as Vice President of CMC and Quality